Regimen | Suitable medications | |
Anti-inflammatory reliever-only therapy ICS–formoterol (single inhaler taken as needed, no maintenance treatment) | Budesonide–formoterol 200/6 microg via DPI: 1 inhalation as needed for symptom relief Budesonide–formoterol 100/3 microg via pMDI: 2 inhalations as needed for symptom relief | |
Maintenance-and-reliever therapy ICS-formoterol (single inhaler used for regular daily maintenance plus extra doses as needed for symptoms) | Low dose (low daily maintenance dose + low reliever doses) Beclometasone–formoterol 100/6 microg via pMDI: daily maintenance dose (1 inhalation twice daily) plus 1 inhalation as needed for symptom relief Budesonide–formoterol 100/3 microg via pMDI: daily maintenance dose (4 inhalations per day) plus 2 inhalations as needed for symptom relief Budesonide–formoterol 200/6 microg via DPI: daily maintenance dose (2 inhalations per day) plus 1 inhalation as needed for symptom relief Budesonide–formoterol 100/6 microg via DPI: daily maintenance dose (2 inhalations per day) plus 1 inhalation as needed for symptom relief | |
Medium dose (medium daily maintenance dose + low reliever doses) Budesonide–formoterol 100/3 microg via pMDI: daily maintenance dose (4 inhalations twice daily) plus 2 inhalations as needed for symptom relief Budesonide–formoterol 200/6 microg via DPI: daily maintenance dose (2 inhalations twice daily) plus 1 inhalation as needed for symptom relief | ||
Maintenance ICS (plus as-needed SABA) | Beclometasone dipropionate* Budesonide* Ciclesonide* Fluticasone furoate* Fluticasone propionate* | Plus SABA reliever: Salbutamol 100 microg via pMDI: 1–2 inhalations as needed for symptom relief or Terbutaline 500 microg via DPI: 1 inhalation for symptom relief |
Maintenance ICS–LABA (plus as-needed SABA) | Beclometasone–formoterol* Budesonide–formoterol* Fluticasone furoate–vilanterol* Fluticasone propionate–salmeterol* Fluticasone propionate–formoterol* Mometasone–indacaterol* |
Additional information
DPI: dry powder inhaler; ICS: inhaled corticosteroid; LABA: long-acting beta2 agonist; pMDI: pressurised metered-dose inhaler; SABA: short-acting beta2 agonist
* Refer to approved product information for strengths and dosage